280 related articles for article (PubMed ID: 23212832)
21. Miscarriage rates after dehydroepiandrosterone (DHEA) supplementation in women with diminished ovarian reserve: a case control study.
Gleicher N; Ryan E; Weghofer A; Blanco-Mejia S; Barad DH
Reprod Biol Endocrinol; 2009 Oct; 7():108. PubMed ID: 19811650
[TBL] [Abstract][Full Text] [Related]
22. Effect of inter-cycle interval on oocyte production in humans in the presence of the weak androgen DHEA and follicle stimulating hormone: a case-control study.
Barad DH; Kushnir VA; Lee HJ; Lazzaroni E; Gleicher N
Reprod Biol Endocrinol; 2014 Jul; 12():68. PubMed ID: 25048047
[TBL] [Abstract][Full Text] [Related]
23. Differences in ovarian aging patterns between races are associated with ovarian genotypes and sub-genotypes of the FMR1 gene.
Gleicher N; Kim A; Weghofer A; Barad DH
Reprod Biol Endocrinol; 2012 Sep; 10():77. PubMed ID: 22963248
[TBL] [Abstract][Full Text] [Related]
24. Predictive value of androgens and multivariate model for poor ovarian response.
Guo J; Zhang Q; Li Y; Huang J; Wang W; Huang L; Zhao X; Yang D
Reprod Biomed Online; 2014 Jun; 28(6):723-32. PubMed ID: 24745840
[TBL] [Abstract][Full Text] [Related]
25. Biopsying, fragmentation and autotransplantation of fresh ovarian cortical tissue in infertile women with diminished ovarian reserve.
Lunding SA; Pors SE; Kristensen SG; Landersoe SK; Jeppesen JV; Flachs EM; Pinborg A; Macklon KT; Pedersen AT; Andersen CY; Andersen AN
Hum Reprod; 2019 Oct; 34(10):1924-1936. PubMed ID: 31593582
[TBL] [Abstract][Full Text] [Related]
26. The effect of dehydroepiandrosterone (DHEA) supplementation on women with diminished ovarian reserve (DOR) in IVF cycle: Evidence from a meta-analysis.
Qin JC; Fan L; Qin AP
J Gynecol Obstet Hum Reprod; 2017 Jan; 46(1):1-7. PubMed ID: 28403950
[TBL] [Abstract][Full Text] [Related]
27. AMH has no role in predicting oocyte quality in women with advanced age undergoing IVF/ICSI cycles.
Dai X; Wang Y; Yang H; Gao T; Yu C; Cao F; Xia X; Wu J; Zhou X; Chen L
Sci Rep; 2020 Nov; 10(1):19750. PubMed ID: 33184364
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of dehydroepiandrosterone priming in women with poor ovarian response undergoing IVF/ICSI: a meta-analysis.
Zhang J; Jia H; Diao F; Ma X; Liu J; Cui Y
Front Endocrinol (Lausanne); 2023; 14():1156280. PubMed ID: 37361534
[TBL] [Abstract][Full Text] [Related]
29. Gonadotrophin stimulation for in vitro fertilization significantly alters the hormone milieu in follicular fluid: a comparative study between natural cycle IVF and conventional IVF.
von Wolff M; Kollmann Z; Flück CE; Stute P; Marti U; Weiss B; Bersinger NA
Hum Reprod; 2014 May; 29(5):1049-57. PubMed ID: 24608520
[TBL] [Abstract][Full Text] [Related]
30. Surgical diminished ovarian reserve after endometrioma cystectomy versus idiopathic DOR: comparison of in vitro fertilization outcome.
Roustan A; Perrin J; Debals-Gonthier M; Paulmyer-Lacroix O; Agostini A; Courbiere B
Hum Reprod; 2015 Apr; 30(4):840-7. PubMed ID: 25740883
[TBL] [Abstract][Full Text] [Related]
31. Effect of dehydroepiandrosterone administration in Chinese women over 37 years undergoing assisted reproductive techniques.
Liu X; Wang W; Wang X; Qu Q; Hao C
Eur J Obstet Gynecol Reprod Biol; 2016 Jul; 202():9-13. PubMed ID: 27156150
[TBL] [Abstract][Full Text] [Related]
32. Maternal serum concentration of anti-Müllerian hormone is a better predictor than basal follicle stimulating hormone of successful blastocysts development during IVF treatment.
Sadruddin S; Barnett B; Ku L; Havemann D; Mucowski S; Herrington R; Burggren W
PLoS One; 2020; 15(10):e0239779. PubMed ID: 33044971
[TBL] [Abstract][Full Text] [Related]
33. Effects of dehydroepiandrosterone supplementation on mice with diminished ovarian reserve.
Lin X; Du J; Du Y; Wu R; Fang X; Liao Y; Quan S
Gynecol Endocrinol; 2018 Apr; 34(4):357-359. PubMed ID: 29221424
[TBL] [Abstract][Full Text] [Related]
34. Live-birth rates in very poor prognosis patients, who are defined as poor responders under the Bologna criteria, with nonelective single embryo, two-embryo, and three or more embryos transferred.
Gleicher N; Vega MV; Darmon SK; Weghofer A; Wu YG; Wang Q; Zhang L; Albertini DF; Barad DH; Kushnir VA
Fertil Steril; 2015 Dec; 104(6):1435-41. PubMed ID: 26348275
[TBL] [Abstract][Full Text] [Related]
35. The Role of Androgen Supplementation in Women With Diminished Ovarian Reserve: Time to Randomize, Not Meta-Analyze.
Neves AR; Montoya-Botero P; Polyzos NP
Front Endocrinol (Lausanne); 2021; 12():653857. PubMed ID: 34079524
[TBL] [Abstract][Full Text] [Related]
36. New PCOS-like phenotype in older infertile women of likely autoimmune adrenal etiology with high AMH but low androgens.
Gleicher N; Kushnir VA; Darmon SK; Wang Q; Zhang L; Albertini DF; Barad DH
J Steroid Biochem Mol Biol; 2017 Mar; 167():144-152. PubMed ID: 27993552
[TBL] [Abstract][Full Text] [Related]
37. The Use of Androgen Priming in Women with Reduced Ovarian Reserve Undergoing Assisted Reproductive Technology.
Richardson A; Jayaprakasan K
Semin Reprod Med; 2021 Nov; 39(5-06):207-219. PubMed ID: 34500477
[TBL] [Abstract][Full Text] [Related]
38. Effects of dehydroepiandrosterone on in vivo ovine follicular development.
Narkwichean A; Jayaprakasan K; Maalouf WE; Hernandez-Medrano JH; Pincott-Allen C; Campbell BK
Hum Reprod; 2014 Jan; 29(1):146-54. PubMed ID: 24256992
[TBL] [Abstract][Full Text] [Related]
39. What are the likely IVF/ICSI outcomes if there is a discrepancy between serum AMH and FSH levels? A multicenter retrospective study.
Daney de Marcillac F; Pinton A; Guillaume A; Sagot P; Pirrello O; Rongieres C
J Gynecol Obstet Hum Reprod; 2017 Oct; 46(8):629-635. PubMed ID: 28843783
[TBL] [Abstract][Full Text] [Related]
40. Higher rates of aneuploidy in blastocysts and higher risk of no embryo transfer in recurrent pregnancy loss patients with diminished ovarian reserve undergoing in vitro fertilization.
Shahine LK; Marshall L; Lamb JD; Hickok LR
Fertil Steril; 2016 Oct; 106(5):1124-1128. PubMed ID: 27371114
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
